Clinically relevant radioresistant cell line: a simple model to understand cancer radioresistance. (Q48132579)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29067564 AND SRC:MED&resulttype=core&format=json

8 April 2020

title

Clinically relevant radioresistant cell line: a simple model to understand cancer radioresistance (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29067564 AND SRC:MED&resulttype=core&format=json

8 April 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29067564 AND SRC:MED&resulttype=core&format=json

8 April 2020

author name string

Mehryar Habibi Roudkenar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29067564 AND SRC:MED&resulttype=core&format=json

8 April 2020

Yusuke Urushihara

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29067564 AND SRC:MED&resulttype=core&format=json

8 April 2020

Yohei Saito

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29067564 AND SRC:MED&resulttype=core&format=json

8 April 2020

Kazuo Tomita

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29067564 AND SRC:MED&resulttype=core&format=json

8 April 2020

Amaneh Mohammadi Roushandeh

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29067564 AND SRC:MED&resulttype=core&format=json

8 April 2020

Tomoaki Sato

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29067564 AND SRC:MED&resulttype=core&format=json

8 April 2020

Akihiro Kurimasa

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29067564 AND SRC:MED&resulttype=core&format=json

8 April 2020

Manabu Fukumoto

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29067564 AND SRC:MED&resulttype=core&format=json

8 April 2020

publication date

24 October 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29067564 AND SRC:MED&resulttype=core&format=json

Medical Molecular Morphology

8 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29067564 AND SRC:MED&resulttype=core&format=json

8 April 2020

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29067564 AND SRC:MED&resulttype=core&format=json

8 April 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29067564 AND SRC:MED&resulttype=core&format=json

8 April 2020

page(s)

195-204

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29067564 AND SRC:MED&resulttype=core&format=json

Cancer and radiation therapy: current advances and future directions

8 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Excellent local control and survival after postoperative or definitive radiation therapy for sarcomas of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

W. C. Roentgen and the discovery of the Roentgen rays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Radiation oncology: a century of achievements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Cellular and molecular mechanisms underlying oxygen-dependent radiosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Radiation and the microenvironment - tumorigenesis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Tumor radioresistance in clinical radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Nrf2 is a potential therapeutic target in radioresistance in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Roles of glucose transporter-1 and the phosphatidylinositol 3‑kinase/protein kinase B pathway in cancer radioresistance (review).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Differentiation pathways in carcinogenesis and in chemo- and radioresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Epidermal Growth Factor Receptor in Glioma: Signal Transduction, Neuropathology, Imaging, and Radioresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Targeting molecular determinants of tumor chemo-radioresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Radioresistance in carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Cyclin D1 overexpression perturbs DNA replication and induces replication-associated DNA double-strand breaks in acquired radioresistant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Clinically relevant radioresistant cells efficiently repair DNA double-strand breaks induced by X-rays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Biological response of cancer cells to radiation treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Targeting the AKT/GSK3β/Cyclin D1/Cdk4 Survival Signaling Pathway for Eradication of Tumor Radioresistance Acquired by Fractionated Radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Isogenic radiation resistant cell lines: development and validation strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Development and characterization of an isogenic cell line with a radioresistant phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Action of x-rays on mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Action of x-rays on mammalian cells. II. Survival curves of cells from normal human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

The modified high-density survival assay is the useful tool to predict the effectiveness of fractionated radiation exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Fractionated irradiation induced radio-resistant esophageal cancer EC109 cells seem to be more sensitive to chemotherapeutic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Radioresistant cell strain of human fibrosarcoma cells obtained after long-term exposure to x-rays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Microarray analysis of DNA damage repair gene expression profiles in cervical cancer cells radioresistant to 252Cf neutron and X-rays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Differential gene expression profiles of radioresistant oesophageal cancer cell lines established by continuous fractionated irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

HeLa cells 50 years on: the good, the bad and the ugly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Cell density dependent plating efficiency affects outcome and interpretation of colony forming assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Autophagy: cellular and molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Disrupting the mTOR signaling network as a potential strategy for the enhancement of cancer radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Cytotoxic autophagy in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Promotion of autophagy as a mechanism for radiation sensitization of breast tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Prolonged autophagy by MTOR inhibitor leads radioresistant cancer cells into senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Enhancement of autophagy is a potential modality for tumors refractory to radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Targeting of tumor endothelial cells combining 2 Gy/day of X-ray with Everolimus is the effective modality for overcoming clinically relevant radioresistant tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Treatment resistance of solid tumors: role of hypoxia and anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Inhibitors of the mammalian target of rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Everolimus for advanced pancreatic neuroendocrine tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Radiation sensitivity, H2AX phosphorylation, and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Alterations in DNA repair efficiency are involved in the radioresistance of esophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Counteracting tumor radioresistance by targeting DNA repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

The Relationship between Cellular Radiosensitivity and Radiation-Induced DNA Damage Measured by the Comet Assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Guanine nucleotide-binding protein 1 is one of the key molecules contributing to cancer cell radioresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

The Involvement of Mitochondrial Membrane Potential in Cross-Resistance Between Radiation and Docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Loss of EGF-dependent cell proliferation ability on radioresistant cell HepG2-8960-R.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Reverse resistance to radiation in KYSE-150R esophageal carcinoma cell after epidermal growth factor receptor signal pathway inhibition by cetuximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Radiosensitivity enhancement of radioresistant glioblastoma by epidermal growth factor receptor antibody-conjugated iron-oxide nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

Radiosensitisation of U87MG brain tumours by anti-epidermal growth factor receptor monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00795-017-0171-X

The proliferative capacity of mouse fibrosarcoma cells that survived x-irradiation

21 January 2018

1 reference

12 December 2020

Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma

1 reference

12 December 2020

Excellent local control from radiation therapy for high-risk neuroblastoma

1 reference

12 December 2020

Cyclin D1 overexpression enhances radiation-induced apoptosis and radiosensitivity in a breast tumor cell line

1 reference

12 December 2020

Acquired radioresistance of human tumor cells by DNA-PK/AKT/GSK3beta-mediated cyclin D1 overexpression

1 reference

12 December 2020

Predicting the tumor response to radiotherapy using microarray analysis (Review).

1 reference

12 December 2020

The comet assay: a method to measure DNA damage in individual cells

1 reference

12 December 2020

10.1007/S00795-017-0171-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29067564 AND SRC:MED&resulttype=core&format=json

8 April 2020

1 reference